Your Location：
Home >
Browse articles >
Intervention Mechanism of Biejiajian Wan on Primary Liver Cancer by Regulating lncRNA SNHG5/miRNA-26a-5p/GSK-3β Signal Axis
Updated：2024-01-15
Previous|Next

    • Intervention Mechanism of Biejiajian Wan on Primary Liver Cancer by Regulating lncRNA SNHG5/miRNA-26a-5p/GSK-3β Signal Axis

    • SHAO Fanlei , CHEN Qiuping , BI Qian , DU Bingzhao , LIU Weihong , SHAO Mingyi
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 4, Pages: 107-113(2024)

    • DOI： 10.13422/j.cnki.syfjx.20230730     

      CLC：

    Scan QR Code

  •  
  •  

  • Full Text(HTML)

  • Figs( 2 ) Tabs( 6 )

  • References

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

202

Views

134

Downloads

3

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Anti-liver Cancer Mechanisms of Biejiajian Wan and Clinical Research： A Review
Traditional Chinese Medicine Treatment of Liver Cancer Based on Hippo Signaling Pathway： A Review
Anti-liver Cancer Effect of Traditional Chinese Medicine Monomers Based on AMPK/mTOR Signaling Pathway： A Review
Treatment of Liver Cancer by Intervening TGF-β Signaling Pathway with Traditional Chinese Medicine： A Review
Chinese Medicine Regulates Nrf2 Signaling Pathway for Treating Hepatic Fibrosis： A Review

Related Author

ZHU Ranpei
ZHANG Hua
LI Xiaoqing
LIU Mengya
LI Chenchen
ZHENG Yuling
HU Yang
HU Suqin

Related Institution

The Second Affiliated Hospital of Henan University of Chinese Medicine
Second Affiliated Hospital of Henan University of Chinese Medicine
Hubei Provincial Hospital of Integrated Chinese & Western Medicine
Gansu University of Chinese Medicine
First Clinical College，Hubei University of Chinese Medicine